在急性髓性白血病中准男性:治疗进展和未来方向
Sandhya Dhiman1, Vikram Dhillon1,2, Suresh Kumar Balasubramanian1
1Department of Oncology, Karmanos Cancer Center, School of Medicine, Wayne State University, Detroit, MI 48201, USA.
Cancers
|November 27, 2024
概括
抑制敏蛋白相互作用对治疗急性髓性白血病 (AML) 有希望,特别是在复发或耐药病例中. 梅宁抑制剂破坏关键的癌症驱动途径,导致白血病细胞分化,并提供新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 在MEN1基因的生殖基因突变导致多重内分泌瘤1型 (MEN1) 综合征.
- 梅宁蛋白与急性髓性白血病 (AML) 有关,特别是在KMT2A重组和NPM1-突变的亚型中,这些亚型的预后不好.
研究的目的:
- 审查抑制AML中menin相互作用的治疗潜力.
- 讨论梅因在白血病发病过程中的作用以及梅因抑制剂的发展.
主要方法:
- 审查关于肌肉生物学的当前文献,其在AML中的作用,以及新兴的治疗策略.
- 针对 menin-KMT2A 相互作用的小分子抑制剂的作用机制分析.
主要成果:
- 破坏menin-KMT2A相互作用可以促进AML细胞的分化.
- 门因抑制剂显示出作为单一疗法和AML联合治疗的前景.
- 在AML中早期临床前和临床评估的脑膜抑制剂显示出令人鼓舞的结果.
结论:
- 针对肌肉相互作用是AML的一种有前途的治疗策略,特别是在难以治疗的患者群体中.
- 梅宁抑制剂可能通过向其他白血病亚组中的类似依赖性来提供更广泛的治疗潜力.
关键词:
在 KMT2A 中.在MLL中,我们可以看到MLL.在 NPM1 中,急性髓性白血病 (AML) 是一种疾病.表观遗传学是指表观遗传学.聚变蛋白质的融合蛋白质在我看来,这是一件非常有趣的事情.有针对性的治疗.更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.1K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.2K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K